Suchergebnisse - "Domingo, Jason"

PubPharm (5)

1

Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R) : a randomised, parallel-arm, open-label, phase 4 trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Hall, F. | Cheriyan, J. | Cope, A. | +113

2

Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP) : a prospective, multicentre, cohort study

enthalten in: EClinicalMedicine | 2023

von Liu, Z. | Alexander, J. | Le, K. | +70

3

Human Cytomegalovirus Infection of Epithelial Cells Increases SARS-CoV-2 Superinfection by Upregulating the ACE2 Receptor

enthalten in: The Journal of infectious diseases | 2023

von Perera, M. | Greenwood, E. | Crozier, T. | +107

4

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

enthalten in: Gastroenterology | 2023

von Liu, Z. | Alexander, J. | Lin, K. | +70

5

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups

enthalten in: Frontiers in immunology | 2023

von Hurler, L. | Szilágyi, �. | Mescia, F. | +126

1
[1]